HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife's 10.3% Slump Tracks With Full-Year Guidance But Light Seen At The End Of 2022

Executive Summary

Herbalife reported a double digit decrease in net sales during its second quarter, following similar results in the first quarter. The direct seller also plans to launch its digital platform Herbalife One to connect distributers and consumers and promote sales.

You may also be interested in...



HBW US Market News: FTC Returns 'Free Trial' Losses, Old Spice Targets 'Meat Sweats,' More

FTC returns more than $5.4m to more than 100,000 consumers from "free trial" scam;" Hood College names Nutrition Science Program's founding director; Cremer introduces gummy-counting machine; Herbalife renovates LA headquarters; Arby's and Old Spice team up to fight "meat sweats."

Herbalife Expects In-Person Events Will Spur Results From ‘Pandemic Cohort’ Of Distributors

Herbalife reported $1.3bn net sales in latest quarter, 11% off previous year on lack of in-person sales experiences from distributors recruited during pandemic.

Warning Confirms Some Supplement GMP Violations Remain Common In US

An Oregon factory’s citations received by the FDA are among the most common violations the agency finds during inspections, ORA Office of Human and Animal Food Operations deputy director said.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS152789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel